Literature DB >> 21495226

Part 2: Ovarian failure in adolescent cancer survivors should be treated.

Avner Hershlag1, Mary E Rausch, Matthew Cohen.   

Abstract

Teenage girls who have survived childhood and adolescent cancer are at risk of losing ovarian function as a result of treatment. This iatrogenic complication may compromise their ability to conceive in the future. In addition, the more immediate consequence is interference in the physical, sexual, and psychosocial development of the female adolescent and her ability to "graduate" into young adulthood. This paper lends strong support to meticulous, graduated hormone replacement, mimicking Tanner's stages of pubertal development, to allow smooth transition of adolescent cancer survivors into adulthood.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21495226     DOI: 10.1016/j.jpag.2010.11.002

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  4 in total

1.  Immunoisolating poly(ethylene glycol) based capsules support ovarian tissue survival to restore endocrine function.

Authors:  James R Day; Anu David; Alexa L Cichon; Tanay Kulkarni; Marilia Cascalho; Ariella Shikanov
Journal:  J Biomed Mater Res A       Date:  2018-02-05       Impact factor: 4.396

Review 2.  Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist.

Authors:  Stacy Tessler Lindau; Emily M Abramsohn; Shirley R Baron; Judith Florendo; Hope K Haefner; Anuja Jhingran; Vanessa Kennedy; Mukta K Krane; David M Kushner; Jennifer McComb; Diane F Merritt; Julie E Park; Amy Siston; Margaret Straub; Lauren Streicher
Journal:  CA Cancer J Clin       Date:  2016-01-19       Impact factor: 508.702

Review 3.  Premature ovarian insufficiency: the context of long-term effects.

Authors:  A Podfigurna-Stopa; A Czyzyk; M Grymowicz; R Smolarczyk; K Katulski; K Czajkowski; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2016-04-18       Impact factor: 4.256

4.  Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice.

Authors:  James Ronald Day; Anu David; Mayara Garcia de Mattos Barbosa; Margaret Ann Brunette; Marilia Cascalho; Ariella Shikanov
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.